These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1797 related articles for article (PubMed ID: 25304375)
21. Honeybee venom possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer cell line. Kim YW; Chaturvedi PK; Chun SN; Lee YG; Ahn WS Oncol Rep; 2015 Apr; 33(4):1675-82. PubMed ID: 25633640 [TBL] [Abstract][Full Text] [Related]
22. Inhibition of HPV 16 E6 oncogene expression by RNA interference in vitro and in vivo. Niu XY; Peng ZL; Duan WQ; Wang H; Wang P Int J Gynecol Cancer; 2006; 16(2):743-51. PubMed ID: 16681755 [TBL] [Abstract][Full Text] [Related]
23. C/EBPbeta activity and HPV-16 E6/E7 mRNA expression are not altered by imiquimod (ALDARA) in human cervical cancer cells in vitro. Belcastro M; Miller MR; Flynn DC; Soisson AP Gynecol Oncol; 2004 Feb; 92(2):660-8. PubMed ID: 14766263 [TBL] [Abstract][Full Text] [Related]
25. Recombinant adenovirus-p53 gene transfer and cell-specific growth suppression of human cervical cancer cells in vitro and in vivo. Ahn WS; Bae SM; Lee KH; Lee JM; Namkoong SE; Chun HJ; Kim CK; Kim YW Gynecol Oncol; 2004 Feb; 92(2):611-21. PubMed ID: 14766255 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of cervical cancer cell growth in vitro and in vivo with lentiviral-vector delivered short hairpin RNA targeting human papillomavirus E6 and E7 oncogenes. Gu W; Putral L; Hengst K; Minto K; Saunders NA; Leggatt G; McMillan NA Cancer Gene Ther; 2006 Nov; 13(11):1023-32. PubMed ID: 16810314 [TBL] [Abstract][Full Text] [Related]
27. TALEN-mediated targeting of HPV oncogenes ameliorates HPV-related cervical malignancy. Hu Z; Ding W; Zhu D; Yu L; Jiang X; Wang X; Zhang C; Wang L; Ji T; Liu D; He D; Xia X; Zhu T; Wei J; Wu P; Wang C; Xi L; Gao Q; Chen G; Liu R; Li K; Li S; Wang S; Zhou J; Ma D; Wang H J Clin Invest; 2015 Jan; 125(1):425-36. PubMed ID: 25500889 [TBL] [Abstract][Full Text] [Related]
28. The synergistic therapeutic effect of cisplatin with Human papillomavirus E6/E7 short interfering RNA on cervical cancer cell lines in vitro and in vivo. Jung HS; Erkin OC; Kwon MJ; Kim SH; Jung JI; Oh YK; Her SW; Ju W; Choi YL; Song SY; Kim JK; Kim YD; Shim GY; Shin YK Int J Cancer; 2012 Apr; 130(8):1925-36. PubMed ID: 21630254 [TBL] [Abstract][Full Text] [Related]
29. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways. Goodwin EC; DiMaio D Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12513-8. PubMed ID: 11070078 [TBL] [Abstract][Full Text] [Related]
30. Silencing E6/E7 Oncoproteins in SiHa Cells Treated with siRNAs and Oroxylum indicum Extracts Induced Apoptosis by Upregulating p53/pRb Pathways. Sisin NNT; Kong AR; Edinur HA; Jamil NIN; Che Mat NF Appl Biochem Biotechnol; 2024 Jul; 196(7):4234-4255. PubMed ID: 37922032 [TBL] [Abstract][Full Text] [Related]
31. Tanshinone IIA inhibits glucose metabolism leading to apoptosis in cervical cancer. Liu Z; Zhu W; Kong X; Chen X; Sun X; Zhang W; Zhang R Oncol Rep; 2019 Nov; 42(5):1893-1903. PubMed ID: 31485631 [TBL] [Abstract][Full Text] [Related]
32. In vitro and in vivo inhibition of human papillomavirus type 16 E6 and E7 genes. Tan TM; Ting RC Cancer Res; 1995 Oct; 55(20):4599-605. PubMed ID: 7553636 [TBL] [Abstract][Full Text] [Related]
33. Sensitivity to Fas-mediated apoptosis in high-risk HPV-positive human cervical cancer cells: relationship with Fas, caspase-8, and Bid. Hougardy BM; van der Zee AG; van den Heuvel FA; Timmer T; de Vries EG; de Jong S Gynecol Oncol; 2005 May; 97(2):353-64. PubMed ID: 15863130 [TBL] [Abstract][Full Text] [Related]
34. Human papilloma virus 16 E6 RNA interference enhances cisplatin and death receptor-mediated apoptosis in human cervical carcinoma cells. Tan S; Hougardy BM; Meersma GJ; Schaap B; de Vries EG; van der Zee AG; de Jong S Mol Pharmacol; 2012 May; 81(5):701-9. PubMed ID: 22328720 [TBL] [Abstract][Full Text] [Related]
35. Hyperthermia Selectively Targets Human Papillomavirus in Cervical Tumors via p53-Dependent Apoptosis. Oei AL; van Leeuwen CM; ten Cate R; Rodermond HM; Buist MR; Stalpers LJ; Crezee J; Kok HP; Medema JP; Franken NA Cancer Res; 2015 Dec; 75(23):5120-9. PubMed ID: 26573798 [TBL] [Abstract][Full Text] [Related]
36. Inhibitory effect of Lonicera japonica-derived exosomal miR2911 on human papilloma virus. Chi Y; Shi L; Lu S; Cui H; Zha W; Shan L; Shen Y J Ethnopharmacol; 2024 Jan; 318(Pt B):116969. PubMed ID: 37516391 [TBL] [Abstract][Full Text] [Related]
37. HPV-16 E6/E7 promotes cell migration and invasion in cervical cancer via regulating cadherin switch in vitro and in vivo. Hu D; Zhou J; Wang F; Shi H; Li Y; Li B Arch Gynecol Obstet; 2015 Dec; 292(6):1345-54. PubMed ID: 26093522 [TBL] [Abstract][Full Text] [Related]
38. Tanshinone IIA inhibits human prostate cancer cells growth by induction of endoplasmic reticulum stress in vitro and in vivo. Chiu SC; Huang SY; Chen SP; Su CC; Chiu TL; Pang CY Prostate Cancer Prostatic Dis; 2013 Dec; 16(4):315-22. PubMed ID: 24042854 [TBL] [Abstract][Full Text] [Related]
39. Activation of the retinoblastoma tumor suppressor mediates cell cycle inhibition and cell death in specific cervical cancer cell lines. Bourgo RJ; Braden WA; Wells SI; Knudsen ES Mol Carcinog; 2009 Jan; 48(1):45-55. PubMed ID: 18506774 [TBL] [Abstract][Full Text] [Related]
40. Effect of ferric ions on reactive oxygen species formation, cervical cancer cell lines growth and E6/E7 oncogene expression. Poljak-Blazi M; Jaganjac M; Sabol I; Mihaljevic B; Matovina M; Grce M Toxicol In Vitro; 2011 Feb; 25(1):160-6. PubMed ID: 21044880 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]